Research ArticleArticle
A Systematic In Vitro Investigation of the Inhibitor Preincubation Effect on Multiple Classes of Clinically Relevant Transporters
Péter Tátrai, Patrick Schweigler, Birk Poller, Norbert Domange, Roelof de Wilde, Imad Hanna, Zsuzsanna Gáborik and Felix Huth
Drug Metabolism and Disposition July 2019, 47 (7) 768-778; DOI: https://doi.org/10.1124/dmd.118.085993
Péter Tátrai
Solvo Biotechnology, Budapest, Hungary (P.T., R.d.W., Z.G.); Novartis Institutes for Biomedical Research, Basel, Switzerland (P.S., B.P., N.D., F.H.); and Novartis Institutes for Biomedical Research, East Hanover, New Jersey (I.H.)
Patrick Schweigler
Solvo Biotechnology, Budapest, Hungary (P.T., R.d.W., Z.G.); Novartis Institutes for Biomedical Research, Basel, Switzerland (P.S., B.P., N.D., F.H.); and Novartis Institutes for Biomedical Research, East Hanover, New Jersey (I.H.)
Birk Poller
Solvo Biotechnology, Budapest, Hungary (P.T., R.d.W., Z.G.); Novartis Institutes for Biomedical Research, Basel, Switzerland (P.S., B.P., N.D., F.H.); and Novartis Institutes for Biomedical Research, East Hanover, New Jersey (I.H.)
Norbert Domange
Solvo Biotechnology, Budapest, Hungary (P.T., R.d.W., Z.G.); Novartis Institutes for Biomedical Research, Basel, Switzerland (P.S., B.P., N.D., F.H.); and Novartis Institutes for Biomedical Research, East Hanover, New Jersey (I.H.)
Roelof de Wilde
Solvo Biotechnology, Budapest, Hungary (P.T., R.d.W., Z.G.); Novartis Institutes for Biomedical Research, Basel, Switzerland (P.S., B.P., N.D., F.H.); and Novartis Institutes for Biomedical Research, East Hanover, New Jersey (I.H.)
Imad Hanna
Solvo Biotechnology, Budapest, Hungary (P.T., R.d.W., Z.G.); Novartis Institutes for Biomedical Research, Basel, Switzerland (P.S., B.P., N.D., F.H.); and Novartis Institutes for Biomedical Research, East Hanover, New Jersey (I.H.)
Zsuzsanna Gáborik
Solvo Biotechnology, Budapest, Hungary (P.T., R.d.W., Z.G.); Novartis Institutes for Biomedical Research, Basel, Switzerland (P.S., B.P., N.D., F.H.); and Novartis Institutes for Biomedical Research, East Hanover, New Jersey (I.H.)
Felix Huth
Solvo Biotechnology, Budapest, Hungary (P.T., R.d.W., Z.G.); Novartis Institutes for Biomedical Research, Basel, Switzerland (P.S., B.P., N.D., F.H.); and Novartis Institutes for Biomedical Research, East Hanover, New Jersey (I.H.)

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
A Systematic Investigation of Inhibitor Preincubation
Péter Tátrai, Patrick Schweigler, Birk Poller, Norbert Domange, Roelof de Wilde, Imad Hanna, Zsuzsanna Gáborik and Felix Huth
Drug Metabolism and Disposition July 1, 2019, 47 (7) 768-778; DOI: https://doi.org/10.1124/dmd.118.085993
Research ArticleArticle
A Systematic Investigation of Inhibitor Preincubation
Péter Tátrai, Patrick Schweigler, Birk Poller, Norbert Domange, Roelof de Wilde, Imad Hanna, Zsuzsanna Gáborik and Felix Huth
Drug Metabolism and Disposition July 1, 2019, 47 (7) 768-778; DOI: https://doi.org/10.1124/dmd.118.085993
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement